Rovia vs Tickertape for US stocks: RSU tooling vs research-first investing

Rovia and Tickertape share the same headline brokerage rate — 0.15% per trade — which is the lowest available among mainstream India-facing US investing platforms. That similarity makes the comparison worth doing carefully, because the similarity ends there.

Rovia and Tickertape are built for genuinely different audiences. Rovia is purpose-built for Indian residents with equity compensation from US employers. Tickertape is research-first: its USP is the screener-to-execution workflow, built on the research platform that Indian investors have used for years to analyse Indian and now US equities.

If you know which you are — an RSU holder or a research-driven individual stock investor — the comparison resolves quickly. If you are both, or neither, read on.

Full disclosure: Vested.blog is the editorial publication of Rovia. This comparison reflects our honest assessment of both platforms.

---

The route: both LRS, slightly different plumbing

Both Rovia and Tickertape use the LRS (Liberalised Remittance Scheme) route for Indian residents funding their accounts. The TCS and LRS cap mechanics are the same:

• 0% TCS on the first ₹7 lakh of aggregate annual LRS remittances
• 20% TCS on amounts above ₹7 lakh per financial year (creditable at ITR; blocks capital until refund)
• $250,000 annual LRS cap applies

The plumbing differs: Rovia clears through Alpaca Securities LLC (FINRA/SIPC). Tickertape clears through ViewTrade International (IFSCA-registered as a Global Access Provider) via GlomoPay for the FX and transfer leg.

Note on ViewTrade: ViewTrade's IFSCA registration means it operates within GIFT City for regulatory purposes — but Tickertape's investor-facing product still uses the standard LRS remittance route, not the GIFT City domestic transfer route. TCS and LRS cap apply as normal for Tickertape users.

Both have SIPC-equivalent protections via their respective clearing infrastructure. Alpaca is a FINRA-member US broker-dealer with SIPC coverage up to $500,000. ViewTrade's investor protection framework is IFSCA-regulated — a different regulatory authority, but designed to provide equivalent protections within the GIFT City framework.

---

Brokerage: identical

Platform	Brokerage	Cap
Rovia	0.15% per trade	None
Tickertape	0.15% per trade	None specified
Vested	0.25% per trade	$35 per order
INDmoney	0.25% per trade	$35 per order
Dhan	0.25% per trade	None specified

The brokerage is the same. At ₹10 lakh invested annually, both platforms cost ₹1,500 in brokerage on the buy side — ₹1,000 less than Vested or INDmoney. This is not a decision factor between the two.

---

RSU consolidation: Rovia only

The clearest difference in the comparison.

Rovia supports inbound ACATS transfers from Fidelity, E*TRADE, Schwab, and Morgan Stanley. This lets you move vested RSU shares from your employer broker to Rovia without selling — preserving cost basis, lot dates, and the 24-month India LTCG holding period. The shares arrive at Alpaca with the original vest dates intact.

Tickertape does not support inbound ACATS transfers. If your RSU shares are at a US employer broker, your choices on Tickertape are: (a) sell on the employer platform, repatriate the cash, reinvest in Tickertape — triggering capital gains and destroying your lot-level history — or (b) keep the RSU shares at the employer platform and use Tickertape only for separately funded investments.

Neither is a good outcome for an RSU holder trying to consolidate. If you have meaningful employer equity at a US broker, Rovia is the relevant platform and Tickertape is not.

---

Research tooling: Tickertape significantly ahead

This is Tickertape's defining advantage.

Tickertape was built as a research and screener platform for Indian equities before it added US stock investing. The research infrastructure extended to US stocks gives investors:

• Screeners: Filter across hundreds of metrics — revenue growth, PE ratio, gross margin, debt/equity, market cap, dividend yield — across the full NYSE/NASDAQ universe. Comparable to what Bloomberg or FactSet provides to institutional investors, in a retail-accessible interface.
• Peer comparison: Put two or more US stocks side by side on key financial metrics in a single table. Compare Nvidia vs AMD vs Intel on revenue growth, gross margin, PE, and R&D spend in seconds.
• Historical PE bands: Visualise where a stock is trading relative to its own 5-year PE range — a quick read on whether it is expensive or cheap relative to its own history.
• Backtesting: Test a historical strategy — "what would a monthly SIP into QQQ from 2015 to 2024 have returned in INR terms?" — without building a spreadsheet.
• Research-to-execution: Screen for ideas, open the stock page for fundamental data, run a peer comparison, and place a buy order — all without leaving Tickertape.

Rovia has no comparable research tooling. Rovia is an execution and portfolio management platform, not a research platform. If you pick stocks based on screener analysis, peer comparisons, and fundamental data, Tickertape's integrated research workflow is a genuine productivity advantage that Rovia does not offer.

---

Tax tooling: Rovia significantly ahead

The inverse applies on tax documentation.

Rovia provides:

• Lot-level INR cost basis with vest-date SBI TT rates pre-applied per lot
• Specific-lot identification at sell (HIFO, LIFO, FIFO, or manual lot selection)
• India 24-month LTCG countdown per lot
• Automated Schedule FA with SBI TT-rate converted peak balance
• Realized-loss schedule with carry-forward tracker for tax-loss harvesting
• Form 67 / Form 44 prep for dividend foreign tax credits

Tickertape provides:

• Standard account statements with transaction history in USD
• Capital gains schedules for CA use
• No specific-lot identification at sell — defaults to FIFO
• No INR cost basis per lot
• No Schedule FA helper
• No tax-loss harvesting reports

For an investor making four purchases per year into VOO, the difference is manageable — a good CA can handle the conversion. For an RSU holder with 10–15 vest events across two or three employers, the absence of lot-level INR cost basis and specific-lot sell workflows on Tickertape means substantially more manual work at filing time, and more risk of FIFO-induced unnecessary tax.

---

FX on repatriation

Rovia: Flat $5 fee on outbound repatriation. The USD-to-INR conversion is done by your Indian bank at their rate. That is the full platform cost.

Tickertape: GlomoPay handles the FX on the outbound leg. The specific markup is not prominently disclosed in Tickertape's published pricing. Verify the current FX markup directly at tickertape.in/us-stocks/pricing before repatriating large amounts.

The Rovia flat $5 structure means the platform's repatriation cost does not scale with amount. A $5,000 repatriation and a $50,000 repatriation both cost $5 on the Rovia side.

---

Asset universe

Both platforms cover the major NYSE and NASDAQ stocks and ETFs that most investors need. Neither offers US options, futures, or OTC (pink-sheet) stocks. Neither offers London-listed or European-listed securities.

Tickertape's catalog spans the full NYSE/NASDAQ universe with fractional shares. Rovia's launch universe covers major stocks and ETFs — the full S&P 500 and NASDAQ-100 constituents — with UCITS and global exchange listings on the Q2/Q3 2026 roadmap.

For most investors, the catalog difference is not material for day-to-day needs. For investors who need specific smaller-cap or OTC names, Tickertape or INDmoney (which has explicit OTC support) may be relevant.

---

Full comparison table

Dimension	Rovia	Tickertape
Underlying clearing	Alpaca Securities (FINRA/SIPC)	ViewTrade International (IFSCA)
Remittance route	LRS	LRS (via GlomoPay)
TCS	0% up to ₹7L; 20% above	0% up to ₹7L; 20% above
Brokerage	0.15% per trade	0.15% per trade
Inbound ACATS (RSU transfer)	Yes — via Alpaca	No
Lot-level INR cost basis	Yes — vest-date SBI TT per lot	No
Specific-lot identification at sell	Yes — default workflow	No — defaults to FIFO
Tax-loss harvesting report	Yes — with carry-forward tracker	No
Schedule FA helper	Yes — automated, SBI TT rates	No
Form 67 / Form 44 prep	Yes	No
Research screeners (US stocks)	No	Yes — comprehensive
Backtesting	No	Yes
Historical PE bands	No	Yes
Peer comparison	No	Yes
Outbound repatriation cost	Flat $5 fee	GlomoPay FX markup (verify)
OTC stocks	No	No
Indian portfolio integration	No	Partial
Platform maturity	2025	Research established; US investing 2024+

---

Who should use which

Rovia is the right choice if you:

• Have RSU or ESPP shares at Fidelity, E*TRADE, Schwab, or Morgan Stanley that you want to consolidate without selling
• Need lot-level INR tax tooling — vest-date SBI TT cost basis, specific-lot identification, automated Schedule FA, loss-harvesting reports
• Are investing below the ₹7L TCS threshold where the route difference is irrelevant and tax tooling is the main differentiator
• Want a predictable flat $5 outbound repatriation cost regardless of amount

Tickertape is the right choice if you:

• Research individual US stocks based on fundamentals — screeners, PE bands, peer comparison — and want to execute in the same platform
• Are already a Tickertape user for Indian stocks and want US investing integrated without a second platform
• Do not have RSU exposure and the research-driven workflow is your primary need
• Value backtesting capability before committing capital to a strategy

Neither is the right choice if you:

• Need options, futures, or international exchange access → IBKR via Paasa
• Are remitting ₹15L+ per year and want to avoid TCS → Dhan (GIFT City route)
• Want the most mature, all-in-one Indian + US wealth app → INDmoney

---

Related reading

• Tickertape US stocks guide 2026
• Rovia vs Vested: which platform is right for your US stock situation?
• Tickertape vs Vested for US stocks
• RSU lot selection and tax-loss harvesting
• Best US stock platform for Indian investors 2026

---

Vested.blog is the editorial publication of Rovia.